ATE193726T1 - Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung - Google Patents

Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Info

Publication number
ATE193726T1
ATE193726T1 AT92302004T AT92302004T ATE193726T1 AT E193726 T1 ATE193726 T1 AT E193726T1 AT 92302004 T AT92302004 T AT 92302004T AT 92302004 T AT92302004 T AT 92302004T AT E193726 T1 ATE193726 T1 AT E193726T1
Authority
AT
Austria
Prior art keywords
nucleotide sequence
specific nucleotide
containing specific
strain containing
measles virus
Prior art date
Application number
AT92302004T
Other languages
English (en)
Inventor
Keiko Sasaki
Takayuki Mori
Satoshi Makino
Original Assignee
Kitasato Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Inst filed Critical Kitasato Inst
Application granted granted Critical
Publication of ATE193726T1 publication Critical patent/ATE193726T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT92302004T 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung ATE193726T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3293625A JP3045581B2 (ja) 1991-10-14 1991-10-14 麻疹ワクチンウイルス株同定方法

Publications (1)

Publication Number Publication Date
ATE193726T1 true ATE193726T1 (de) 2000-06-15

Family

ID=17797135

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92302004T ATE193726T1 (de) 1991-10-14 1992-03-10 Spezifische nukleotidsequenz enthaltender masernvirusvakzinstamm und verfahren zu seiner absoluten identifizierung

Country Status (10)

Country Link
US (2) US5654136A (de)
EP (1) EP0540135B1 (de)
JP (1) JP3045581B2 (de)
KR (1) KR950012759B1 (de)
AT (1) ATE193726T1 (de)
DE (1) DE69231143T2 (de)
DK (1) DK0540135T3 (de)
ES (1) ES2148164T3 (de)
GR (1) GR3034278T3 (de)
PT (1) PT540135E (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683211B2 (en) * 1992-04-08 1997-11-06 United States of America as represented by The Secretary Department of Health and Human Services, The Wild-type measles virus glycoproteins: vaccine and detection method therefor
US6638482B1 (en) * 1993-11-01 2003-10-28 Nanogen, Inc. Reconfigurable detection and analysis apparatus and method
EP0920449B1 (de) * 1996-07-31 2002-10-23 Claude P. Muller Peptide abgeleitet aus dem morbillivirus
WO1998013501A2 (en) * 1996-09-27 1998-04-02 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
CA2262500C (en) 1997-06-04 2004-03-16 The Research Foundation For Microbial Diseases Of Osaka University Measles virus mutant antigen and gene coding for the same
IL138681A0 (en) * 1998-03-26 2001-10-31 American Cyanamid Co Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b
WO2001038537A1 (en) * 1999-11-19 2001-05-31 The Kitasato Institute Method of constructing cell-fusion type morbillivirus mutant
CN1188167C (zh) 2000-01-31 2005-02-09 财团法人阪大微生物病研究会 减毒水痘活疫苗质量控制的方法
AU7948000A (en) * 2000-02-10 2001-08-20 Kitasato Inst Method of constructing temperature-sensitive morbilli virus
EP1375512B1 (de) * 2002-06-20 2009-07-22 Institut Pasteur Infektiöse cDNA eines zugelassenen Impfstammes des Masern Virus. Verwendung in immunogenen Zusammensetzungen
ES2427139T3 (es) 2002-06-20 2013-10-29 Institut Pasteur Virus recombinantes del sarampión que expresan epítopos de antígenos de virus de ARN y uso de los virus recombinantes para la preparación de composiciones de vacuna
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
EP2420242A1 (de) 2010-08-20 2012-02-22 Lauer, Ulrich M. Onkolytisches Masernvirus
CN104211769B (zh) * 2013-05-30 2018-08-03 中国科学院过程工程研究所 一种小分子抗体亲和肽及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617261A (en) * 1984-03-21 1986-10-14 Cetus Corporation Process for labeling nucleic acids and hybridization probes
JPS63307827A (ja) * 1987-06-08 1988-12-15 Kitasato Inst:The 安定化された生ウイルスワクチンおよびその製造法
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses

Also Published As

Publication number Publication date
JPH05103665A (ja) 1993-04-27
JP3045581B2 (ja) 2000-05-29
EP0540135A2 (de) 1993-05-05
EP0540135A3 (en) 1993-12-08
GR3034278T3 (en) 2000-12-29
KR930008138A (ko) 1993-05-21
DK0540135T3 (da) 2000-08-07
US5654136A (en) 1997-08-05
KR950012759B1 (ko) 1995-10-21
DE69231143D1 (de) 2000-07-13
ES2148164T3 (es) 2000-10-16
EP0540135B1 (de) 2000-06-07
DE69231143T2 (de) 2000-10-19
PT540135E (pt) 2000-11-30
US5824777A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
DE69231143D1 (de) Spezifische Nukleotidsequenz enthaltender Masernvirusvakzinstamm und Verfahren zu seiner absoluten Identifizierung
ATE238434T1 (de) Eine in kaskaden verlaufende vervielfältigungsreaktion von nukleinsäuren
ATE172642T1 (de) Impfstoffe und verfahren zu ihrer herstellung
DE3888425D1 (de) Virale Expressionsinhibitoren.
ATE353973T1 (de) Die verwendung der 3'-wesentlichen bearbeitungswirksamkeit von dns-polymerase
ATE197479T1 (de) Verfahren zur vervielfältigung von nukleinsäuresequenzen
FI930658A0 (fi) Oligonukleotider foer modulering av effekten av cytomegalovirusinfektioner
FI893526A7 (fi) Välineitä ja menetelmä nukleiinihappohybridisaation lisäämiseksi
NZ244089A (en) Characterising genomic dna samples into individual sample codes using amplification and type specific primers to form a database of individual sample codes
ATE111523T1 (de) Dns-sequenzen des menschlichen papillomavirus typ 52 und verfahren zu ihrer verwendung.
EP0754765A3 (de) DNS Sequenzierung und DNS Kettenabbrecher
ZA925259B (en) Immobilization of nucleic acids
EP0438292A3 (en) Method of preparing primers for polymerase chain reaction and dna amplification using said primers
CA2066998A1 (en) Recombinant varicella-zoster virus and process for constructing same
NO940658D0 (no) Nukleinsyre-polymerase-forökning
NZ239883A (en) Oligonucleotides and compositions and methods for inhibiting the growth of microbes, viruses and self-replicating nucleic acids
DK0527941T3 (da) Identifikation af hidtil ukendte lægemidler og reagenser
FI920636A7 (fi) DNA-koettimia ja alukkeita B. burgdorferin havaitsemiseksi polymeraasi ketjureaktiota käyttäen
DE3887710D1 (de) 1-(3,5-Di-0-benzoyl-2-deoxy-beta-D-threo-pentofuranosyl)Thymine und Verfahren zu deren Herstellung.
DK727688D0 (da) Malariaspecifikke dna-sekvenser, deres expressionsprodukter samt anvendelsen heraf
DE69230345D1 (de) Nachweis von einem genort
ATE108834T1 (de) Spezifische nukleinsäurefragmente des menschlichen villingens, ihre anwendung für diagnostische zwecke.
RU93013954A (ru) Способ обнаружения вируса иммунодефицита
NO875058L (no) Oligonukleotidprober og fremgangsmÿte for detektering av nukleinsyrene i bakterier og andre levende organismer ved hybridisering.
KR940012633U (ko) 핵산(dna) 증폭 배양기

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification